Brief: Sedana Medical Q4 EBITDA Loss Widens To SEK 13 Mln

Sedana Medical AB (publ)

17/02/2022 06:21

Feb 17 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL AB FOURTH QUARTER AND YEAR-END REPORT 2021
    * Q4 NET SALES SEK 46 MILLION VERSUS SEK 46 MILLION YEAR AGO
    * Q4 GROSS PROFIT WAS MSEK 33 (30)
    * Q4 EBITDA TOTALLED MSEK -13 (-6)
    * Q4 EBIT TOTALLED MSEK-19 (-8)
    * BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND BE PAID FOR
2021
FINANCIAL YEAR.

Source text for Eikon:  ID:nWkr8gNwFq 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))